HELLS and cancer: HELLS is mutated or misregulated in tumour samples from several cancer types (27–31) and is also mutated in some cases of immunodeficiency-centromeric instability-facial anomalies syndrome (ICF), characterized by instability within pericentromeric repeats (32).